Aducanumab (BIIB037), a human monoclonal antibody selective for aggregated forms of amyloid beta (Abeta). Aducanumab shows brain penetration, and can be used for Alzheimers disease (AD) research.
Purity:
>99.0%
CAS Number:
[1384260-65-4]
Target:
Amyloid
* VAT and and shipping costs not included. Errors and price changes excepted